In 2022, the global Canine Arthritis Treatment Market Size was estimated to be worth US$ 2.39 billion. The market for pharmaceuticals used to treat canine arthritis is predicted to increase at a CAGR of 4.2% through 2028, with a market value of $3.05 billion. In 2021, canine arthritis therapeutic pharmaceuticals were responsible for 17.2% of the global rare inflammatory disease treatment market.
Canine arthritis is a degenerative joint disease in dogs that causes inflammation, cartilage deterioration, and long-term joint problems. The most commonly damaged joints in animals are the knees, elbows, shoulders, hips, and spine. Injuries, obesity, and poor bone development are some of the reasons of canine arthritis in dogs.
Get Sample Report + Related Graphs & Charts@ https://www.futuremarketinsights.com/reports/sample/rep-gb-3552
The global canine arthritis treatment market is expected to grow significantly during the forecast period, owing to an increase in dog ownership worldwide, the development of veterinary healthcare infrastructure, and the expansion of treatment options for canine arthritis, according to Future Market Insights. This growth is being driven by the rising prevalence of obesity-induced arthritis in dogs, as well as increased awareness of companion animal health. Furthermore, the FDA’s simplified approval process for new and revolutionary canine arthritis therapy drugs will create opportunities for market participants to thrive.
Key Takeaways from Canine Arthritis Treatment Market Study
- Nonsteroidal anti-inflammatory drugs are a veterinarian’s first line of defence against inflammation and pain. Tingling, allergic responses, swelling, and discomfort have all been demonstrated to be relieved by these medications. Unlike unapproved NSAIDs, canine authorised nonsteroidal anti-inflammatory medications have a satisfactory safety record.
- Growth prospects for the North American canine arthritis market are favourable when compared to other regions, owing to increased canine adoption, increased veterinary expenditure on their health, and greater pet health awareness.
- Market participants have remained focused on veterinary hospitals and clinics, which offer full animal care and service support for improved pet health.
- Oral formulations of major non-steroidal anti corticosteroids medications will continue to account for major share of the manufacturers’ bottom lines, in the view of increasing demand for their ease of administration and better animal compliance.
Ask More About This Market’s Geographical Distribution Along With a Detailed Analysis of the Top Regions@ https://www.futuremarketinsights.com/ask-question/rep-gb-3552
Competitive Landscape
Elanco, Ceva Sante Animale, Boehringer Ingelheim are among the leading players in the canine arthritis treatment market. These manufacturers continue to dominate the market landscape of canine arthritis treatment by ensuring product availability, collaborating with the local distributors, strengthening manufacturing facilities, and strategizing R&D for diversification of product portfolio.
Key Players
- Boehringer Ingelheim International GmbH.
- DAIICHI SANKYO COMPANY, LIMITED
- Thorne
- NUTRI-VET
- American Regent, Inc.
- DSM
- Zoetis
- National hog farmer
- Novasep
- Bayer AG
- Matsun Nutrition
Buy Now to Gain Access to Detailed Information About Each Segment and Identify Key Trends, Drivers, and Challenges in the Market@ https://www.futuremarketinsights.com/checkout/3552
Key Segments Of Canine Arthritis Treatment Industry Survey
Canine Arthritis Treatment Market by Treatment:
- Non-steroidal Anti-inflammatory Drugs (NSAIDs)
- Opioids
- Stem Cell Therapy
- Allogeneic Stem Cells
- Autologous Stem Cells
Canine Arthritis Treatment Market by Route of Administration:
- Oral Canine Arthritis Treatment
- Injectable Canine Arthritis Treatment
Canine Arthritis Treatment Market by Distribution Channel:
- Veterinary Hospitals & Clinics
- Retail Pharmacies
- Drug Stores
- e-Commerce
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
